Chapter 16. CRS+HIPEC in Epithelial Ovarian Cancer (EOC) with peritoneal dissemination
Thematic
VIDEOS 16: CRS+HIPEC in Epithelial Ovarian Cancer (EOC) with peritoneal dissemination
CRS+HIPEC in Epithelial Ovarian Cancer:
16.1: CRS+HIPEC: FIGO IIIB epithelial ovarian cancer
16.2: CRS+HIPEC: FIGO IIIC epithelial ovarian cancer
16.3: CRS+HIPEC: epithelial ovarian cancer FIGO IV
16.4: CRS+HIPEC: peritoneal recurrence of ovarian cancer
16.5: Primary surgical treatment of advanced borderline ovarian cancer
16.6: CRS+HIPEC: peritoneal recurrence of borderline ovarian cancer
Video 16.1: CRS+HIPEC: FIGO IIIB epithelial ovarian cancer
Video 16.2: CRS+HIPEC: FIGO IIIC epithelial ovarian cancer
Video 16.3: CRS+HIPEC: epithelial ovarian cancer FIGO IV
Video 16.4: CRS+HIPEC: peritoneal recurrence of ovarian cancer
Video 16.5: Primary surgical treatment of advanced borderline ovarian cancer
Video 16.6: CRS+HIPEC: peritoneal recurrence of borderline ovarian cancer
CRS+HIPEC in other gynecological tumors:
16.7: CRS+HIPEC in endometrial cancer recurrence (surgery and previous RDT)
16.8: CRS+HIPEC in primary peritoneal cancer recurrence
16.9: CRS+HIPEC in recurrence of endocervical mucinous adenocarcinoma
16.10: CRS+HIPEC in uterine sarcoma
16.11: CRS+HIPEC in the recurrence of immature teratoma (G2)